CLUSTER filed Aug 14, 2026 at 16:18 ET
Medpace CEO August Troendle sold $21.1M in stock over a 3-day window (Aug 10-12), with a director selling an additional $690K. This cluster of insider selling is significant in absolute dollar terms but represents only ~0.02% of Medpace's $13.6B market cap, making it proportionally trivial. The selling is concentrated in the CEO, which carries more weight, but the lack of any insider buying and the routine nature of the sales (open-market, not 10b5-1) suggests a neutral-to-slightly-bearish signal that is unlikely to move the stock on its own.